title: Warfarin treatment in patients with atrial fibrillation and advanced chronic kidney disease: sins of omission or commission?
authors.affiliation: Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California2Department of Health Research and Policy, Stanford University School of Medicine, Palo Alto, California3Associate Editor, JAMA.
authors.forename: Wolfgang C
authors.initials: WC
authors.lastname: Winkelmayer
authors.affiliation: Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Palo Alto, California5Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
authors.forename: Mintu P
authors.initials: MP
authors.lastname: Turakhia
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications*; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin